2024
|
G/S
|
Pharmaceuticals; pharmaceutical preparations and substances;
pharmaceutical preparations, namely... |
|
G/S
|
Pharmaceuticals; pharmaceutical preparations and substances; pharmaceutical preparations, namely,... |
|
Invention
|
Gene therapies for phenylketonuria. Polynucleotides and polynucleotide sequences encoding phenyla... |
|
Invention
|
Improved crispr/cas guide rna (grna). Modified guide RNAs for EV-mediated delivery of gene editin... |
2023
|
G/S
|
Pharmaceuticals for the treatment of cancer, diabetes, metabolic syndrome, dementia, and other ag... |
|
G/S
|
Pharmaceuticals for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and... |
|
Invention
|
Tspan2 as scaffold protein for engineered extracellular vesicles. The present invention pertains ... |
2022
|
Invention
|
Therapeutic delivery vesicles.
The present invention pertains to inter alia methods for purifyin... |
|
Invention
|
Engineered extracellular vesicles with improved cargo delivery. An engineered extracellular vesic... |
|
G/S
|
Pharmaceuticals, namely, drug delivery agents in the form of exosomes consisting of compounds tha... |
|
Invention
|
Exosomes comprising therapeutic polypeptides.
The present invention pertains to an inventive rel... |
|
Invention
|
Nanoparticle delivery system for production of engineered extracellular vesicles. The present inv... |
|
Invention
|
Modified extracellular vesicles (evs) with improved half-life.
A modified Extracellular Vesicle ... |
|
Invention
|
Modified extracellular vesicles (evs) with improved half-life. A modified Extracellular Vesicle (... |
|
Invention
|
Cell penetrating peptide (cpp)-mediated ev loading.
The present invention relates to methods for... |
2021
|
Invention
|
Extracellular vesicle comprising a fusion protein having fc binding capacity.
The present invent... |
|
Invention
|
Engineered extracellular vesicles displaying enhanced pharmacokinetics.
The present invention re... |
|
Invention
|
Engineered extracellular vesicles displaying enhanced pharmacokinetics. The present invention rel... |
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cancer, diabetes, obesity, metabo... |
|
Invention
|
Extracellular vesicles with improved half-life.
The present invention pertains to extracellular ... |
|
Invention
|
Extracellular vesicles with improved half-life. The present invention pertains to extracellular v... |
|
Invention
|
Targeted delivery of extracellular vesicles.
The present disclosure relates compartmental admini... |
|
Invention
|
Targeted delivery of extracellular vesicles. The present disclosure relates compartmental adminis... |
2020
|
Invention
|
Nanoparticle-like delivery system.
The present invention pertains to a new nanoparticle-like del... |
|
Invention
|
Nanoparticle-like delivery system. The present invention pertains to a new nanoparticle-like deli... |
|
G/S
|
Chemical reagents; Pharmaceuticals; pharmaceutical preparations and substances; pharmaceutical pr... |
|
Invention
|
Exosome comprising stabilized rna therapeutics.
The present invention pertains to extracellular ... |
|
Invention
|
Exosome comprising stabilized rna therapeutics. The present invention pertains to extracellular v... |
|
Invention
|
Compositions of exosomes and aav.
The present disclosure relates to extracellular vesicles, e.g.... |
|
Invention
|
Compositions of exosomes and aav. The present disclosure relates to extracellular vesicles, e.g.,... |
|
Invention
|
Therapeutic delivery vesicles. The present invention pertains to inter alia methods for purifying... |
2019
|
Invention
|
Extracellular vesicles for replacement of urea cycle proteins & nucleic acids.
The present inven... |
|
Invention
|
Extracellular vesicles for replacement of urea cycle proteins & nucleic acids. The present invent... |
|
Invention
|
Combinatorial gene therapy.
The present invention relates to administration of gene therapy, in ... |
|
Invention
|
Combinatorial gene therapy. The present invention relates to administration of gene therapy, in p... |
|
Invention
|
Engineering extracellular vesicles for affinity purification.
The present invention pertains to ... |
|
Invention
|
Engineering extracellular vesicles for affinity purification. The present invention pertains to a... |
|
Invention
|
Cell-mediated exosome delivery.
The present invention relates to engineered cells that enable ex... |
|
Invention
|
Cell-mediated exosome delivery. The present invention relates to engineered cells that enable exo... |
|
Invention
|
Compositions for extracellular vesicle storage and formulation.
The present invention relates to... |
|
Invention
|
Compositions for extracellular vesicle storage and formulation. The present invention relates to ... |
|
Invention
|
Intracellular delivery of target-silencing protein.
The present invention relates to extracellul... |
|
Invention
|
Intracellular delivery of target-silencing protein. The present invention relates to extracellula... |
2018
|
Invention
|
Protein engineered extracellular vesicles.
The present invention relates to extracellular vesicl... |
|
Invention
|
Exosomes comprising rna therapeutics.
The present invention pertains to extracellular vesicle (E... |
|
Invention
|
Affinity purification of engineered extracellular vesicles. The present invention pertains to aff... |
|
Invention
|
Improved loading of evs with therapeutic proteins.
The present invention pertains to improved me... |
2017
|
Invention
|
Uses of extracellular vesicle comprising a fusion protein having fc binding capacity.
The presen... |
|
Invention
|
Extracellular vesicle comprising a fusion protein having fc binding capacity. The present inventi... |
|
Invention
|
Ev-mediated delivery of binding protein-small molecule conjugates.
The present invention relates... |
|
Invention
|
Cell penetrating peptide (cpp)-mediated ev loading. The present invention relates to methods for ... |
2016
|
G/S
|
Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical prepa... |